SAFEs vs. Convertible Notes vs. Priced Rounds

Pricing a company at pre-seed is genuinely hard

At pre-seed, there's often too little evidence, no revenue, no users, sometimes no finished product, to defend a specific valuation with any confidence. Rather than argue over a number neither side can support, most early rounds use an instrument that defers the pricing question to later, when there's more evidence.

The three instruments

A SAFE (Simple Agreement for Future Equity) is not debt: it has no interest rate and no maturity date, and it converts into equity at the next priced round. A convertible note is technically a loan, it carries interest and a maturity date, and it converts into equity instead of being repaid in cash, assuming the company raises a priced round before the note matures. A priced round sets an actual valuation today and issues real shares (usually preferred stock) immediately, no future conversion event required.

Why angels see mostly SAFEs

SAFEs dominate pre-seed and seed rounds because they're fast and cheap to paper (often a single standardized document, popularized by Y Combinator), require no valuation negotiation, and don't burden an unproven company with debt-like maturity obligations. Priced rounds become more common starting at Series A, once there's enough evidence, revenue, growth, retention, for both sides to defend a specific number. As an angel, expect to see SAFEs far more often than the other two instruments, which is why Lesson 6 goes deep on the two terms that actually decide your price on one.